AJOVY Trademark

Trademark Overview

On Tuesday, November 15, 2016, a trademark application was filed for AJOVY with the United States Patent and Trademark Office. The USPTO has given the AJOVY trademark a serial number of 87237174. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, April 3, 2025. This trademark is owned by Teva Pharmaceutical Industries Limited. The AJOVY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of migraines
ajovy

General Information

Serial Number87237174
Word MarkAJOVY
Filing DateTuesday, November 15, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, April 3, 2025
Registration Number5633449
Registration DateTuesday, December 18, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of migraines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 21, 2016
Primary Code005
First Use Anywhere DateWednesday, September 19, 2018
First Use In Commerce DateWednesday, September 19, 2018

Trademark Owner History

Party NameTEVA PHARMACEUTICALS INTERNATIONAL GMBH
Party Type31 - New Owner After Registration
Legal Entity Type27 - NOT AVAILABLE
AddressJONA 8645
CH
Party NameTeva Pharmaceutical Industries Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL
Party NameTeva Pharmaceutical Industries Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJerusalem 91010
IL
Party NameTeva Pharmaceutical Industries Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events

Event DateEvent Description
Tuesday, April 4, 2017PUBLISHED FOR OPPOSITION
Friday, November 18, 2016NEW APPLICATION ENTERED
Monday, November 21, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 22, 2017ASSIGNED TO EXAMINER
Thursday, February 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 24, 2018SOU EXTENSION 2 GRANTED
Tuesday, April 4, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 16, 2017SOU TEAS EXTENSION RECEIVED
Thursday, November 16, 2017SOU EXTENSION 1 FILED
Thursday, November 16, 2017SOU EXTENSION 1 GRANTED
Saturday, November 18, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 24, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 24, 2018SOU TEAS EXTENSION RECEIVED
Thursday, May 24, 2018SOU EXTENSION 2 FILED
Wednesday, November 14, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 18, 2018REGISTERED-PRINCIPAL REGISTER
Monday, December 18, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, May 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 27, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, September 27, 2018USE AMENDMENT FILED
Tuesday, October 23, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 25, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 13, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 16, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, December 18, 2024TEAS SECTION 8 & 15 RECEIVED
Thursday, April 3, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 3, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, April 3, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

ajovy migraines treatment preparations pharmaceutical